Top 30 Pharmaceutical Companies in Massachusetts

5 min read

Get started

Trusted by data-driven investors

Massachusetts is home to a thriving pharmaceutical industry, with leading companies pushing the boundaries of drug discovery and biopharmaceutical advancements. From cannabinoid-based therapies by Targeted Pharmaceuticals in Worcester to oncology-focused innovations by TESARO in Waltham, these firms are at the forefront of cutting-edge research in personalized medicine and biotech. Investment opportunities abound in sectors such as oncology, neurology, and antimicrobial resistance, driven by Massachusetts' robust ecosystem of publicly traded companies and dynamic startups.

Ra Pharmaceuticals logo

Ra Pharmaceuticals

🇺🇸 87 Cambridgepark Dr Cambridge, Massachusetts 02140, US

Ra Pharmaceuticals specializes in pharmaceutical manufacturing, focusing on innovative therapies for rare diseases. Its unique approach includes the development of peptide-based treatments, enhancing the effectiveness and precision of drug delivery.

pharmaceuticals
manufacturing
biotechnology
drug development
therapeutics
life sciences
clinical trials
Company size: 5001-10000
Synspira Therapeutics, Inc. logo

Synspira Therapeutics, Inc.

🇺🇸 10 Speen St 302

Engaged in biotechnology research, Synspira Therapeutics focuses on innovative therapeutic solutions, emphasizing advancements in treatment methodologies.

biotechnology
research
therapeutics
pharmaceuticals
drug development
clinical trials
Company size: 2-10
Founded: 2017
Dyax logo

Dyax

🇺🇸 55 Network Drive Burlington, MA 01803, US

Dyax specializes in biotechnology research, focusing on innovative approaches to develop therapies for rare diseases. Its expertise in this niche area enhances its contributions to the biotechnology industry.

biotechnology
research
pharmaceuticals
drug development
clinical trials
therapeutics
genetic engineering
Company size: 51-200

Aurora Biopharma, Inc.

🇺🇸 ONE MIFFLIN PL Cambridge, Massachusetts 02138, us

Aurora Biopharma, Inc. specializes in research services within the biopharmaceutical industry, focusing on innovative approaches to drug development and therapeutic solutions.

research
biopharma
clinical trials
pharmaceuticals
biotechnology
drug development
medical research
Company size: 11-50
Founded: 2015
Atea Pharmaceuticals, Inc logo

Atea Pharmaceuticals, Inc

🇺🇸 225 Franklin St Suite, 2100

Atea Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on discovering and developing innovative antiviral therapies for COVID-19 and severe viral diseases, addressing critical unmet medical needs in the biotechnology research industry.

biotechnology
pharmaceuticals
antiviral
clinical-stage
drug discovery
viral diseases
therapeutics
medical research
COVID-19
healthcare
Company size: 51-200
Founded: 2014
Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

🇺🇸 Cambridge, MA 02141, US

Focused on the discovery and development of treatments for neurodegenerative diseases, this pharmaceutical manufacturer specializes in addressing conditions such as ALS, employing a collaborative approach to enhance the lives of those affected.

pharmaceuticals
neurodegenerative
ALS
drug development
clinical trials
therapeutics
research
biotechnology
patient support
Company size: 201-500

Bach Pharma

🇺🇸 North Andover, US

Bach Pharma operates in the biotechnology industry, focusing on innovative solutions for pharmaceutical development and production. Their unique approach emphasizes advanced biotechnological methods to enhance drug efficacy and safety.

biotechnology
pharmaceuticals
drug development
research
clinical trials
therapeutics
Company size: 1
Kiniksa Pharmaceuticals logo

Kiniksa Pharmaceuticals

🇺🇸 100 Hayden Ave Lexington, Massachusetts 02421, US

Kiniksa Pharmaceuticals specializes in biotechnology research, concentrating on the discovery, development, and commercialization of therapeutic medicines for patients with debilitating diseases and significant unmet medical needs. The organization emphasizes a robust pipeline and a skilled team to deliver transformative therapies, showcasing a commitment to innovation and rapid execution in the biopharmaceutical sector.

biopharmaceutical
biotechnology
therapeutic
medicines
research
development
commercialization
clinical trials
drug discovery
unmet medical need
product candidates
Company size: 201-500
Founded: 2015
Targeted Pharmaceuticals logo

Targeted Pharmaceuticals

🇺🇸 60 Prescott St Worcester, Massachusetts 01605, US

Targeted Pharmaceuticals specializes in cannabinoid-based drug discovery and personalized medicine within the pharmaceutical manufacturing industry, focusing on innovative approaches to developing tailored therapeutic solutions.

cannabinoids
pharmaceuticals
marijuana
drug
discovery
medicine
targeted
personalized
therapies
treatments
cannabis
biopharmaceuticals
innovation
research
development
formulations
clinical
efficacy
dosage
extraction
Company size: 2-10
Founded: 2018
Censa Pharmaceuticals Inc. logo

Censa Pharmaceuticals Inc.

🇺🇸 65 William St Wellesley Hills, Massachusetts 02481, US

Censa Pharmaceuticals is focused on developing innovative medicines aimed at improving the lives of patients suffering from debilitating diseases within the biotechnology research industry.

biotechnology
pharmaceuticals
drug development
medicine
patient care
therapeutic research
debilitating diseases
Company size: 1
Arsanis logo

Arsanis

🇺🇸 Winter Street Waltham, MA 02451, US

Arsanis specializes in biotechnology research, focusing on innovative solutions in the pharmaceutical sector. The firm is positioned for growth following its merger with X4 Pharmaceuticals, enhancing its capabilities in developing advanced therapeutic options.

biotechnology
research
pharmaceuticals
mergers
drug development
Company size: 11-50
Founded: 2010

VDA Pharma, Inc.

🇺🇸 108 MARLBOROUGH ST Boston, Massachusetts 02116, us

VDA Pharma, Inc. specializes in the manufacturing of biopharmaceuticals focused on HIV treatment, leveraging innovative approaches to develop effective therapies in the pharmaceutical industry.

pharmaceuticals
biopharmaceuticals
HIV
manufacturing
drug development
healthcare
biotechnology
therapeutics
Company size: 2-10
Founded: 2011
Akashi Therapeutics, Inc. logo

Akashi Therapeutics, Inc.

🇺🇸 245 First Street 18th Floor

Akashi Therapeutics is a clinical stage biotechnology firm focused on developing innovative therapies for Duchenne muscular dystrophy and other rare diseases, with a strong emphasis on muscle regeneration and anti-inflammatory properties through its lead asset HT-100 and the muscle-building SARM DT-200. The organization is distinguished by its foundation through collaboration between patient advocacy groups and seasoned biotechnology professionals.

biotechnology
drug development
clinical trials
muscular dystrophy
rare diseases
anti-inflammatory
anti-fibrotic
muscle regeneration
androgen receptor
muscle mass
strength enhancement
Company size: 2-10
Founded: 2010
Ardelyx, Inc. logo

Ardelyx, Inc.

🇺🇸 400 Fifth Avenue 210

Ardelyx, Inc. specializes in biotechnology research, focusing on the discovery and commercialization of innovative, first-in-class medicines to address significant unmet medical needs. The firm is notable for its development of tenapanor, with multiple approved products targeting conditions such as irritable bowel syndrome and hyperphosphatemia.

biotechnology
pharmaceuticals
drug development
medical research
clinical trials
innovative medicines
unmet medical needs
commercialization
hyperphosphatemia
IBS treatment
Company size: 201-500
Founded: 2007
TAC Biopharmaceuticals LLC logo

TAC Biopharmaceuticals LLC

🇺🇸 Malden, MA 02148, US

TAC Biopharmaceuticals specializes in biotechnology research, offering a comprehensive suite of services that support the development and commercialization of biopharmaceuticals, including generic drugs and biosimilars. With over 25 years of industry experience and a strong emphasis on regulatory expertise and strategic guidance, it empowers clients to navigate the complexities of modern medicine development.

biotechnology
pharmaceutical
biopharmaceutical
regulatory affairs
clinical development
non-clinical development
generic drugs
biosimilars
translational science
project management
business development
strategy development
Company size: 2-10
Founded: 2024

Ascent Therapeutics

🇺🇸 67 Rogers Street Cambridge, MA 02142, US

Ascent Therapeutics specializes in biotechnology research, focusing on innovative therapeutic solutions aimed at advancing healthcare. Their unique approach leverages cutting-edge technology to develop novel treatments for various medical conditions.

biotechnology
research
therapeutics
pharmaceuticals
drug development
clinical trials
healthcare
innovation
Company size: 2-10

Boston Life Sciences Inc

🇺🇸 20 Newbury St # 5 Boston, Massachusetts 02116-3234, US

Boston Life Sciences Inc specializes in biotechnology research, focusing on innovative solutions and advanced methodologies to drive breakthroughs in the life sciences sector.

biotechnology
research
life sciences
pharmaceuticals
drug development
clinical trials
diagnostics
Company size: 11-50

Tarix Pharmaceuticals LTD.

🇺🇸 Brookline, MA, US

Tarix Pharmaceuticals LTD specializes in biotechnology research, focusing on innovative therapeutic solutions to address unmet medical needs. Their unique approach emphasizes the development of novel treatments, positioning them as a key player in advancing healthcare.

biotechnology
pharmaceuticals
research
drug development
clinical trials
therapeutics
life sciences
Company size: 2-10
inVentiv Health Commercial logo

inVentiv Health Commercial

🇺🇸 1 Van de Graaff Drive Boston, MA 02210, US

A fully integrated biopharmaceutical solutions provider, specializing in both clinical and commercial services, that leverages expertise, data, and insights to enhance biopharmaceutical performance in an increasingly complex market. Its unique approach combines Contract Research Organization (CRO) and Contract Commercial Organization (CCO) capabilities to support a wide range of pharmaceutical and biotechnology needs.

biopharmaceutical
clinical services
commercial services
market access
pharmaceutical sales
medical affairs
consulting
biotechnology
healthcare
patient outcomes
therapeutic alignment
Company size: 10001+
Founded: 1999
Hypromatrix Inc logo

Hypromatrix Inc

🇺🇸 100 Barber Ave Worcester, Massachusetts 01606-2464, US

Hypromatrix Inc specializes in biotechnology research, focusing on innovative solutions and advancements in the field. Their expertise positions them at the forefront of developing cutting-edge biotechnological applications.

biotechnology
research
life sciences
pharmaceuticals
genetic engineering
clinical trials
drug development
biomanufacturing
Company size: 2-10

eXIthera Pharmaceuticals LLC

🇺🇸 1900 W Park Dr Westborough, Massachusetts 01581, US

eXIthera Pharmaceuticals specializes in pharmaceutical manufacturing, focusing on innovative therapeutic solutions. The firm is dedicated to advancing healthcare through the development of novel treatments.

pharmaceuticals
manufacturing
drug development
biotechnology
clinical trials
therapeutics
research
formulation
regulatory affairs
quality control
Company size: 2-10
Platform Therapeutics, Inc. logo

Platform Therapeutics, Inc.

🇺🇸 Andover, Massachusetts 01810, US

Platform Therapeutics specializes in biotechnology research, focusing on developing innovative medicines for critically ill patients. Their commitment to addressing urgent medical needs sets them apart in the healthcare industry.

biotechnology
medicine
pharmaceuticals
research
therapeutics
drug development
clinical trials
patient care
Company size: 2-10
Founded: 2022
Nuvelution Pharmaceuticals logo

Nuvelution Pharmaceuticals

🇺🇸 101 Main St Cambridge, MA 02142, US

Nuvelution Pharmaceuticals specializes in biotechnology research, focusing on maximizing the potential of pharmaceutical portfolios through innovative strategies and approaches.

biotechnology
pharmaceuticals
research
portfolio management
drug development
clinical trials
therapeutic innovations
Company size: 2-10

NeuroPhage Pharmaceuticals, Inc.

🇺🇸 85 Bolton St Cambridge, MA 02140, US

NeuroPhage Pharmaceuticals specializes in biotechnology research, focusing on innovative therapies to combat neurodegenerative diseases. Their unique approach leverages cutting-edge science to develop treatments that target the underlying mechanisms of these conditions.

biotechnology
pharmaceuticals
research
drug development
neurodegenerative
therapeutics
clinical trials
molecular biology
Company size: 11-50
EEG/ERP Biomarker Qualification Consortium logo

EEG/ERP Biomarker Qualification Consortium

🇺🇸 Boston, MA, US

A pre-competitive consortium in biotechnology research focused on qualifying, validating, and operationalizing EEG/ERP biomarkers for CNS clinical trials, fostering collaboration among industry, academic, and regulatory stakeholders to enhance the reliability of these biomarkers in clinical settings.

EEG
electroencephalography
neuroscience
mental health
clinical research
clinical trials
pharmaceuticals
psychiatry
neurology
biotechnology
digital health
biomarkers
Company size: 11-50
Novelion Therapeutics logo

Novelion Therapeutics

🇺🇸 Boston, US

Novelion Therapeutics focuses on developing innovative biopharmaceuticals aimed at establishing new standards of care for rare diseases, with a diverse portfolio that includes treatments for metabolic disorders and ongoing research into therapies for inherited retinal diseases. Their commitment to advancing science and clinical development distinguishes them in the biotechnology research industry.

biopharmaceutical
rare diseases
clinical development
gene therapy
retinal disease
drug development
therapeutic portfolio
biotechnology research
Company size: 201-500
Manta Medicines logo

Manta Medicines

🇺🇸 Boston, US

Manta Medicines operates in the biotechnology research industry, focusing on developing innovative medicines aimed at undrugged targets. The organization emphasizes a strategic selection of programs with the potential for multiple indications, aiming to create a diverse portfolio that mitigates risk while enhancing the likelihood of clinical success.

biotechnology
research
pharmaceuticals
drug development
clinical trials
therapeutic targets
portfolio management
indication targeting
Company size: 2-10
Founded: 2022
Oxeia Biopharmaceuticals Inc logo

Oxeia Biopharmaceuticals Inc

🇺🇸 361 Newbury St Boston, Massachusetts 02115, US

Oxeia Biopharmaceuticals is focused on developing innovative therapeutics for mild traumatic brain injury (concussion) and related neuro-metabolic dysfunction, with a clinical-stage drug, OXE103, currently undergoing Phase 2 trials. Their unique approach addresses a significant gap in treatment options for concussion patients, emphasizing the need for more than just rest.

biotechnology
therapeutics
clinical trials
mild traumatic brain injury
neuro-metabolic dysfunction
concussion
drug development
Company size: 2-10
Founded: 2014
X4 Pharmaceuticals logo

X4 Pharmaceuticals

🇺🇸 61 N Beacon St Boston, Massachusetts 02134, US

Specializing in biotechnology research, this clinical biopharmaceutical entity is dedicated to improving the lives of individuals with rare immune disorders by developing innovative treatments, notably mavorixafor, which has gained FDA approval for its first indication. Their patient-centric approach and focus on advancing therapies for underserved populations highlight their commitment to addressing critical healthcare needs.

biopharmaceutical
biotechnology
clinical trials
rare diseases
immune disorders
FDA approval
CXCR4
neutropenia
patient-centric
drug development
Company size: 51-200
Founded: 2014
Alnylam Pharmaceuticals logo

Alnylam Pharmaceuticals

🇺🇸 675 W Kendall St Cambridge, Massachusetts 02142, US

Alnylam Pharmaceuticals is a pioneering biopharmaceutical entity specializing in RNA interference (RNAi) therapeutics, which offers an innovative approach to silencing disease-causing genes. With a robust pipeline of approved therapies, it is at the forefront of developing treatments for both rare and prevalent diseases.

biotechnology
RNAi
therapeutics
drug development
biopharma
rare diseases
gene silencing
clinical trials
pharmaceuticals
innovation
Company size: 1001-5000
Founded: 2002

Updated on

Let our AI browse all websites for you

Save time, improve accuracy, and get ahead of the competition with Cenco.ai.

Get started

You might be interested in